2003
DOI: 10.1016/s0020-7519(03)00158-9
|View full text |Cite
|
Sign up to set email alerts
|

Progress in the development of a recombinant vaccine for human hookworm disease: The Human Hookworm Vaccine Initiative

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
98
0
1

Year Published

2005
2005
2017
2017

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 130 publications
(99 citation statements)
references
References 98 publications
(74 reference statements)
0
98
0
1
Order By: Relevance
“…Our results also confirm that the mechanisms of action of the two larval proteins are different, since only ASP-2 promoted neutrophil migration. Na-ASP-2 has been selected as a vaccine candidate based on human immuno-epidemiologic studies and laboratory animal vaccine trials Goud et al, 2004;Hotez et al, 2003;Mendez et al, 2005). In order to clarify the role of Na-ASP-2 as a functional vaccine, and in an attempt to unravel its function, structural studies were carried out .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Our results also confirm that the mechanisms of action of the two larval proteins are different, since only ASP-2 promoted neutrophil migration. Na-ASP-2 has been selected as a vaccine candidate based on human immuno-epidemiologic studies and laboratory animal vaccine trials Goud et al, 2004;Hotez et al, 2003;Mendez et al, 2005). In order to clarify the role of Na-ASP-2 as a functional vaccine, and in an attempt to unravel its function, structural studies were carried out .…”
Section: Discussionmentioning
confidence: 99%
“…Hookworm proteins involved in tissue invasion are particularly good candidate antigens for the development of vaccines and drugs (Hotez et al, 2003). On the basis of in vitro data, animal trials and human epidemiological studies Goud et al, 2004;Hotez et al, 2003;Mendez et al, 2005), the L3-secreted N. americanus ASP-2 (Na-ASP-2) was selected as a vaccine antigen to undergo further development .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Hookworms account for one third of all nematode infections. Efforts to develop effective vaccines against these parasites have not been successful (1). In general, helminths induce a strong type 2 immune response, which is characterized by high IgE levels and increased numbers of Th2 cells, mast cells, eosinophils, and basophils.…”
mentioning
confidence: 99%
“…Recombinant antigen vaccines against helminth infections have been tested with limited success (8,28,35,36), which in part may be due to the altered conformation and/or glycosylation of the recombinant antigens. An alternative vaccination approach has been to immunize mice with DNA, where the protein product is produced in vivo from the plasmid DNA.…”
mentioning
confidence: 99%